Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The dispersion method does not affect the in vitro genotoxicity of multi-walled carbon nanotubes despite inducing surface alterations.
Burgum MJ, Alcolea-Rodríguez V, Saarelainen H, Portela R, Reinosa JJ, Fernández JF, Dumit VI, Catalán J, Simeone FC, Faccani L, Clift MJD, Evans SJ, Bañares MA, Doak SH. Burgum MJ, et al. Among authors: fernandez jf. NanoImpact. 2024 Dec 21;37:100539. doi: 10.1016/j.impact.2024.100539. Online ahead of print. NanoImpact. 2024. PMID: 39716585 Free article.
Abbreviated or Standard Antiplatelet Therapy After PCI in Diabetic Patients at High Bleeding Risk.
Roffi M, Landi A, Heg D, Frigoli E, Chalkou K, Chevalier B, Ijsselmuiden AJJ, Kastberg R, Komiyama N, Morice MC, Onuma Y, Ozaki Y, Peace A, Pyxaras S, Sganzerla P, Williams R, Xaplanteris P, Vranckx P, Windecker S, Smits PC, Valgimigli M; MASTER DAPT Investigators. Roffi M, et al. JACC Cardiovasc Interv. 2024 Nov 25;17(22):2664-2677. doi: 10.1016/j.jcin.2024.08.030. JACC Cardiovasc Interv. 2024. PMID: 39603779 Clinical Trial.
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Goodman SG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Harrington RA, Jukema JW, White HD, Zeiher AM, Manvelian G, Pordy R, Poulouin Y, Stipek W, Garon G, Schwartz GG; ODYSSEY OUTCOMES Investigators. Goodman SG, et al. Eur Heart J Cardiovasc Pharmacother. 2024 Jul 16;10(4):342-352. doi: 10.1093/ehjcvp/pvae025. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38658193 Free PMC article. Review.
Concomitant Light-Reversible Magnetic Response in Multiferroic Oxide Heterostructures for Multiphysics Applications.
López-Sánchez J, Del Campo A, Quesada A, Rivelles A, Abuín M, Sainz R, Sebastiani-Tofano E, Rubio-Zuazo J, Ochoa DA, Fernández JF, García JE, Rubio-Marcos F. López-Sánchez J, et al. Among authors: fernandez jf. ACS Appl Mater Interfaces. 2024 Apr 17;16(15):19866-19876. doi: 10.1021/acsami.4c02551. Epub 2024 Apr 8. ACS Appl Mater Interfaces. 2024. PMID: 38587105 Free PMC article.
Reversible optical control of magnetism in engineered artificial multiferroics.
Ochoa DA, Menéndez E, López-Sánchez J, Del Campo A, Ma Z, Spasojević I, Fina I, Fernández JF, Rubio-Marcos F, Sort J, García JE. Ochoa DA, et al. Among authors: fernandez jf. Nanoscale. 2024 Feb 29;16(9):4900-4908. doi: 10.1039/d3nr05520e. Nanoscale. 2024. PMID: 38323494 Free PMC article.
129 results